Portfolio
Our first investment reflects the type of company we seek to support: a high-growth, innovative business with a top-tier team, international reach, and a leading position in a Biosciences sector driven by favourable macro trends


EGGNOVO
Biosciences Verticals
Climate & Environment, Sustainable Nutrition, Health & Wellness
Investment Year 2026
Website www.eggnovo.com
Location Navarra
COMPANY DESCRIPTION
Europe’s Leading Producer of Natural Functional Ingredients Derived from Eggshell Membrane
Founded in 2012, Eggnovo is the European leader in natural functional ingredients derived from eggshell membrane. The company develops branded ingredients supported by more than 20 clinical studies and enabled by a proprietary, patented extraction technology platform.
Through a circular economy model embedded in its DNA, Eggnovo transforms several million eggshells each day into high-value ingredients for the nutraceutical industry. Eggshell membrane, naturally rich in over 400 bioactive compounds including collagen, elastin and hyaluronic acid, is used in products supporting joint mobility, skin health and overall wellbeing. In line with its full-shell valorization approach, Eggnovo also utilizes eggshell calcium carbonate to develop ingredients supporting bone health and eco-industrial applications.
Eggnovo commercializes its products in more than 45 countries, generating approximately 90% of revenues internationally, and serves a diversified B2B customer base that includes several of the world's leading nutraceutical and health brands.
The company employs approximately 50 people and continues to expand its innovation pipeline through next-generation soluble formats designed to enhance bioavailability and broaden applications.
Aleos Fit

Biosciences company
All three Aleos verticals involved

Company Size
SME

Transaction type
Growth buyout

Stake
Majority stake

Deal Process
Proprietary deal with exclusivity
